SCHEMBL30091067

CC(C)C(=O)OC[C@H]1O[C@@](C#N)(c2ccc3c(NC(=O)[C@H](Cc4ccc(F)cc4)NC(=O)OC(C)(C)C)ncnn23)[C@@H]2OC(C)(C)O[C@@H]21

nearest known ligand 0.40

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	CTSS	P25774	8/20	0.40

▸	CTSK	P43235	7/20	0.40

▸	TMPRSS2	O15393	1/20	0.35

▸	SCN9A	Q15858	3/20	0.34

▸	PSMB5	P28074	1/20	0.33

▸	CTSL	P07711	1/20	0.33

▸	CTSB	P07858	1/20	0.33

▸	PABPC1	P11940	1/20	0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30090949	0.96	CTSS (0.39)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL25909906	0.95	CTSS (0.41)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL25909477	0.94	CTSS (0.39)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL30090985	0.94	CTSS (0.40)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL25909446	0.92	CTSS (0.42)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL25909472	0.92	CTSS (0.42)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL30090953	0.92	CTSS (0.40)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL25909468	0.92	CTSS (0.40)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL30931396	0.91	CTSS (0.41)	CTSSCTSKTMPRSS2SCN9APSMB5
SCHEMBL30090961	0.90	CTSS (0.37)	CTSSCTSKTMPRSS2SCN9APSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4355755-A1	ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS	Venatorx Pharmaceuticals, Inc. (US)	2024-04-24	—	—	EP	disclosed
WO-2022265964-A1	ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS	VenatoRx Pharmaceuticals, Inc. (US)	2022-12-22	—	—	WO	disclosed